CVS' third-quarter 2024 results reflect strong performance in the Health Services and Pharmacy & Consumer Wellness segments.

CVS Health stock surged over 11% following a sizable revenue beat and the appointment of new CEO David Joyner. See why I'm ...

CVS Health (CVS) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of ...

The stock is down 22% year-to-date. Tesla rallies after Trump wins election. Tesla shares surged 15% after Donald Trump’s ...

CVS Health shows signs of recovery and growth potential. Learn why CVS stock is a buy with improved cash flow and strong ...

CVS Health has an analyst consensus of Moderate Buy, with a price target consensus of $68.15, implying a 26.13% upside from current levels. In a report released on November 11, TD Cowen also ...

Taking into account the latest results, the current consensus from CVS Health's 23 analysts is for revenues of US$385.9b in ...

Shares of CVS Health Corp. CVS shed 7.37% to $57.07 Thursday, on what proved to be an all-around mixed trading session for ...

CVS Health fell short on third-quarter profit, but it posted strong sales and the health care giant shook up leadership under ...

While we acknowledge the potential of CVS as an investment, our conviction lies in the belief that AI stocks hold greater ...

CVS Health (CVS – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Allen Lutz ...